Articles by Kan Hyeong-woo
Kan Hyeong-woo
hwkan@heraldcorp.com-
Celltrion establishes R&D office in Boston
Celltrion has opened a research and development office in Boston to speed up its new drug development efforts in the US while seeking and boosting cooperation with other firms, company officials said Monday. According to company officials, the South Korean biopharmaceutical giant completed the establishment of the Boston office earlier this year. The new US office has been exploring the biotechnology industry’s trends while gathering information on startups and pipelines with investment
Technology Aug. 22, 2022
-
Naver becomes 1st Korean IT firm to join RE100
Naver has become the first South Korean information technology company to join the global RE100 renewable energy initiative to achieve carbon neutrality, the firm said Monday. The RE100 initiative, which is led by the Climate Group in partnership with CDP -- formerly known as Carbon Disclosure Project -- commits members to using 100 percent renewable electricity. Naver said it plans to initiate its “2040 Carbon Negative” roadmap, which was established last year, to meet the goal
Technology Aug. 22, 2022
-
Samsung fund invests $15m in US biotech Senda
Samsung Life Science Fund has invested $15 million in US biotech Senda Biosciences in efforts to foster core technology of next-generation biopharmaceuticals, Samsung Biologics said Wednesday. Senda Biosciences is a therapeutics platform company specialized in programming to the cell by using the code from natural nanoparticles. The US biotech’s platform includes a messenger RNA engine and the first-ever atlas of nature-derived programmable systems at the molecular level and across all k
Market Aug. 17, 2022
-
Korea develops core equipment for NASA’s space telescope
The Korea Astronomy and Space Science Institute has developed core equipment required for the ground testing of NASA’s future space observatory project, the Ministry of Science and ICT said Tuesday. The state-run KASI has put together a cryogenic vacuum chamber for NASA’s project -- Spectro-Photometer for the History of the Universe, Epoch of Reionization, and Ices Explorer, also known as SPHEREx. If successful, the project will mark the world’s first observation of the entir
Technology Aug. 17, 2022
-
SK chairman discusses global health commitments with Gates
SK Group Chairman Chey Tae-won discussed shared commitments to global health with Bill Gates, co-chair of the Bill and Melinda Foundation, SK Bioscience said Wednesday. According to officials, SK Discovery Executive Vice Chairman Chey Chang-won and SK Bioscience CEO Ahn Jae-yong also attended the meeting in Yeouido, western Seoul. The SK leaders and Gates talked about how they can cooperate to improve global health. SK Bioscience said the company and the Bill and Melinda Gates Foundation hav
Industry Aug. 16, 2022
-
SK invests $250m in Bill Gates' TerraPower
SK Group, South Korea’s second-largest conglomerate, has invested $250 million in Bill Gates’ small nuclear power reactor developer TerraPower in an effort to cut down global carbon emissions and build up the group’s green energy portfolio, officials said Monday. According to the group’s announcement, SK Inc. and SK Innovation became co-lead investors of TerraPower’s investment attraction plan worth $750 million along with Gates. The Korean companies’ i
Industry Aug. 15, 2022
-
Galaxy Watch5 adopts most advanced sleep tracking: Samsung exec
Samsung Electronics executive vice president Yang Tae-jong said the IT giant’s newest smart wearable device -- Galaxy Watch5 series -- offers the world’s most advanced sleep-tracking technology in a press conference held Thursday in New York, a day after the Galaxy Unpacked August 2022 event. “Galaxy Watch5 is loaded with various technologies including an innovative bioactive sensor that can measure biometrics to help (users) stay healthy. Galaxy Watch5 will be the best partn
Technology Aug. 15, 2022
-
[Newsmaker] [From the Scene] Korea's 1st domestic COVID-19 vaccine ready
ANDONG, North Gyeongsang Province -- Hundreds of vials were lined up on the belt of a packaging machine at L House, SK Bioscience’s vaccine manufacturing facility in Andong, North Gyeongsang Province, on Wednesday afternoon, as the developer of South Korea’s first homegrown COVID-19 vaccine SKYCovione is poised to roll out the vaccine’s first batch by the end of August. A few technicians, who were covered from head to toe with sterilized gear -- protective shoes, clothing and
Technology Aug. 11, 2022
-
KCC to probe Apple, Google over in-app payment rules
The Korea Communications Commission will look into whether app market operators -- Apple, Google and One Store -- are in violation of a Korean law that bans forcing certain in-app payment methods among app developers, the regulatory agency said Tuesday. The fact-checking investigation will begin from Aug. 16, according to the KCC. App market operators that only allow certain payment options or refuse app registrations or updates of app developers that use external links for in-app purchases co
Technology Aug. 9, 2022
-
Korea to draft frequency plan to support EVs, UAM
The South Korean government will draw up a frequency spectrum plan by the end of this year in efforts to support the growth of new industries such as electric vehicles, robots and urban air mobility, the Ministry of Science and ICT said Tuesday. “We hope that the government’s preemptive supply of frequency and policy improvements will serve as a foundation for Korea to lead the global market in various new industries, including wireless charging of EVs in times of digital transform
Technology Aug. 9, 2022
-
[Herald Interview] Due diligence on partners crucial for Korean biotech out-license deals
Korean biotechnology firms hoping to ink successful deals with foreign pharmaceutical companies must fully comprehend their potential partners’ A to Z’s, a legal expert in out-license deals said. “(Global big pharmas) want something that’s going to be successful and hopefully innovative, and both help patients and provide care, but also be valuable and create profit for the company,” Joshua Hofheimer, a partner and co-head of Global Life Sciences industry group at
Technology Aug. 9, 2022
-
[Newsmaker] Korea to shoot for the moon Friday
South Korea’s first lunar mission Danuri is all set to be launched into space on a SpaceX Falcon rocket on Friday morning, the Ministry of Science and ICT said Thursday. According to the ministry, the SpaceX Falcon rocket has been erected at the Cape Canaveral Space Force Station in Florida as of 11:15 a.m., Korea time. Danuri, formally known as the Korea Pathfinder Lunar Orbiter, will blast off at 8:08 a.m. on Friday, Korea time, or 7:08 p.m. on Thursday, local Eastern Standard time.
Technology Aug. 4, 2022
-
Researchers develop mass production technology for biodegradable microrobots
Scientists have developed a new technology to allow mass production of biodegradable microrobots that are likely to contribute to improving the efficacy of regenerative medicine such as stem cell therapy, Daegu Gyeongbuk Institute of Science and Technology said Tuesday. A joint research team composed of scientists at DGIST, Seoul St. Mary’s Hospital of The Catholic University of Korea and Swiss public university ETH Zurich came up with a method to produce over 100 biodegradable microrobo
Technology Aug. 2, 2022
-
LG Chem looks to begin final stage of clinical trials for gout drug with FDA
LG Chem has applied for phase 3 clinical trials of its gout treatment candidate Tigulixostat with the US Food and Drug Administration, the South Korean company said Monday. If the application gets the go-ahead sign from the FDA, it will mark the first time for LG Chem to carry out phase 3 clinical trials of its self-developed new drug candidate globally including in the US, according to the company. Gout is a painful form of arthritis that is characterized by sudden, severe attacks of pain, sw
Technology Aug. 1, 2022
-
SK Bioscience eyes Europe as market for COVID-19 vaccine
SK Bioscience has submitted the application for conditional approval of the COVID-19 vaccine SKY Covione with the European Medicines Agency in efforts to expand its presence in the global market, the South Korean vaccine developer said Monday. Beginning with the European region, SK Bioscience said it will look to showcase the South Korean COVID-19 vaccine on the global stage as the size of the coronavirus vaccine market grows rapidly. South Korea’s Ministry of Food and Drug Ministry gav
Technology Aug. 1, 2022
Most Popular
-
1
Korea’s homegrown nanosatellite successfully launches into space
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
-
3
Nicaragua shuts down Seoul embassy
-
4
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
-
5
Hybe's multilabel system tested amid conflict with Ador
-
6
SNU profs to suspend treatment for one day
-
7
SK hynix pledges W20tr to ramp up DRAM production at home
-
8
Over-50s, men, single-person households take up majority of those filing for bankruptcy
-
9
Ministry denies blame for Jamboree debacle
-
10
Pianist Cho Seong-Jin named Berlin Philharmonic's artist-in-residence